Immunotech Biopharm Ltd

Immunotech Biopharm Ltdverified

6978.HK

Price:

$2.88

Market Cap:

$1.34B

Immunotech Biopharm Ltd, a cellular immunotherapy biopharmaceutical company, focuses on the research, development, and commercialization of T cell immunotherapy products for the treatment of cancers in the People's Republic of China. Its core product is EAL, a multi-target cellular immunotherapy product that is in Phase II clinical trials for the prevention of postsurgical recurrence of liver cancer. The company is also conducting pre-clinical and clinical trial studies for EAL to treat lung cancer, glioma, gastric cancer, and colorectal cancer. In addition, it develops 6B11-OCIK injection that is in Phase I clinical trial for ovarian cancer; CAR-T-19 injection product for B-cell acute lymph...[Read more]

Industry

Biotechnology

IPO Date

2020-07-10

Stock Exchange

HKSE

Ticker

6978.HK

The Enterprise Value as of December 2025 (TTM) for Immunotech Biopharm Ltd (6978.HK) is 1.43B

According to Immunotech Biopharm Ltd’s latest financial reports and current stock price. The company's current Enterprise Value is 1.43B. This represents a change of -18.19% compared to the average of 1.75B of the last 4 quarters.

Immunotech Biopharm Ltd (6978.HK) Historical Enterprise Value (quarterly & annually)

How has 6978.HK Enterprise Value performed in the past?

The mean historical Enterprise Value of Immunotech Biopharm Ltd over the last ten years is 4.21B. The current 1.43B Enterprise Value has changed 3.30% with respect to the historical average. Over the past ten years (40 quarters), 6978.HK's Enterprise Value was at its highest in in the June 2021 quarter at 7.71B. The Enterprise Value was at its lowest in in the June 2018 quarter at 0.

Quarterly (TTM)
Annual

Average

4.21B

Median

3.34B

Minimum

1.18B

Maximum

6.81B

Immunotech Biopharm Ltd (6978.HK) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Immunotech Biopharm Ltd Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 103.88%

Maximum Annual Enterprise Value = 6.81B

Minimum Annual Increase = -67.79%

Minimum Annual Enterprise Value = 1.18B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20241.18B-53.68%
20232.55B16.16%
20222.20B-67.79%
20216.81B103.88%
20203.34B-49.89%
20196.67B-0.41%

Immunotech Biopharm Ltd (6978.HK) Average Enterprise Value

How has 6978.HK Enterprise Value performed in the past?

The current Enterprise Value of Immunotech Biopharm Ltd (6978.HK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

1.98B

5-year avg

3.22B

10-year avg

4.21B

Immunotech Biopharm Ltd (6978.HK) Enterprise Value vs. Peers

How is 6978.HK’s Enterprise Value compared to its peers?

Immunotech Biopharm Ltd’s Enterprise Value is greater than 3D Medicines Inc. (1.19B), greater than Zhaoke Ophthalmology Limited (712.75M), greater than JW (Cayman) Therapeutics Co. Ltd (743.94M), greater than Genor Biopharma Holdings Limited (593.99M), greater than Transcenta Holding Limited (1.01B), greater than Brii Biosciences Limited (-495752424.28), greater than Wuhan YZY Biopharma Co Ltd (1.23B), less than SinoMab BioScience Limited (1.92B), greater than Sirnaomics Ltd. (111.01M), greater than Sunho Biologics, Inc. (846.85M),

Build a custom stock screener for Immunotech Biopharm Ltd (6978.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Immunotech Biopharm Ltd using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Immunotech Biopharm Ltd (6978.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Immunotech Biopharm Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Immunotech Biopharm Ltd's Enterprise Value?

What is the highest Enterprise Value for Immunotech Biopharm Ltd (6978.HK)?

What is the 3-year average Enterprise Value for Immunotech Biopharm Ltd (6978.HK)?

What is the 5-year average Enterprise Value for Immunotech Biopharm Ltd (6978.HK)?

How does the current Enterprise Value for Immunotech Biopharm Ltd (6978.HK) compare to its historical average?